文献速递皮肤肿瘤

亚洲肢端雀斑样黑素瘤患者前哨淋巴结活检标本中存在淋巴结黑素细胞痣的临床特征与预后

Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen.
PubMed 文献 · J Am Acad Dermatol · 2018-04-16

该回顾性单中心研究分析了2010年6月至2017年7月间84例接受前哨淋巴结活检的亚洲肢端雀斑样黑素瘤患者,其中9例(10.7%)活检标本中存在淋巴结黑素细胞痣。淋巴结黑素细胞痣与前哨淋巴结活检标本及既存黑素细胞病变相关(P < .001),且其患者5年总生存率显著高于前哨淋巴结阳性患者(P = .047),远处复发率显著低于前哨淋巴结阳性患者(P = .03)。

要点

  • 84例亚洲肢端雀斑样黑素瘤患者中9例(10.7%)前哨淋巴结活检标本存在淋巴结黑素细胞痣。
  • 既存黑素细胞病变与淋巴结黑素细胞痣的存在相关(P < .001)。
  • 伴淋巴结黑素细胞痣患者5年总生存率显著高于前哨淋巴结阳性患者(P = .047),远处复发率显著更低(P = .03)。

核心结论

  • 在亚洲人群中,肢端雀斑样黑素瘤患者淋巴结黑素细胞痣的患病率与欧洲和美国报道相似。
  • 伴淋巴结黑素细胞痣的肢端雀斑样黑素瘤患者的远处复发率和总生存率与无转移性黑素瘤的患者相似。

研究设计与样本

  • 回顾性分析2010年6月至2017年7月间接受前哨淋巴结活检的84例肢端雀斑样黑素瘤患者。
  • 单中心研究设计。

主要发现

  • 84例肢端雀斑样黑素瘤患者中,9例(10.7%)前哨淋巴结活检标本中存在淋巴结黑素细胞痣。
  • 淋巴结黑素细胞痣在前哨淋巴结活检标本中显著比非前哨淋巴结活检标本更常见。
  • 既存黑素细胞病变的存在与淋巴结黑素细胞痣相关(P < .001)。
  • 伴淋巴结黑素细胞痣的肢端雀斑样黑素瘤患者5年总生存率显著高于前哨淋巴结阳性患者(P = .047)。
  • 伴淋巴结黑素细胞痣的肢端雀斑样黑素瘤患者远处复发显著低于前哨淋巴结阳性患者(P = .03)。

局限性

  • 样本量小。
  • 单中心研究设计。
  • 研究的回顾性性质。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nodal melanocytic nevi (NNs) encountered during sentinel lymph node biopsy (SLB) for malignant melanoma are usually difficult to distinguish from metastatic melanoma. However, NNs have not been well studied in acral lentiginous melanoma (ALM) in Asian populations. OBJECTIVE: To investigate the clinical characteristics and significance of NNs in SLB specimens from patients with ALM. METHODS: We retrospectively analyzed 84 patients with ALM who underwent SLB between June 2010 and July 2017. RESULTS: Of the 84 patients with ALM, 9 (10.7%) had NNs in their SLB specimens. NNs were significantly more common in SLB specimens than in specimens not obtained by SLB. The presence of pre-existing melanocytic lesions was found to be associated with NNs (P < .001). The 5-year overall survival was significantly higher in patients with ALM with NNs than in patients with a positive SLB result (P = .047). Distant recurrence in patients with ALM with NNs was significantly lower than in patients a positive SLB result (P = .03). LIMITATIONS: The small sample size, single-center study design, and retrospective nature of the study were the limitations. CONCLUSION: In Asian populations, the prevalence of NNs in ALM is similar to that reported in Europe and the United States. The rates of distant recurrence and overall survival in patients with ALM who have NNs are similar to those of patients who do not have metastatic melanoma.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Kim HJ, Seo JW, Roh MS, et al. Clinical features and prognosis of Asian patients with acral lentiginous melanoma who have nodal nevi in their sentinel lymph node biopsy specimen. J Am Acad Dermatol. 2018. PMID: 29673774. doi:10.1016/j.jaad.2018.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。